Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic - Full Text View

Sponsored by:	Hamilton Health Sciences
Information provided by:	McMaster University
ClinicalTrials.gov Identifier:	NCT00248027

Purpose

Main Research questions:

Who are the patients referred for treatment at the Psychotic Disorders Clinic?
What are the outcomes from treatment for first episode psychosis in multiple outcome domains?
What hospital resources are used over the early course of the illness?
How satisfied are patients and family with the treatment and services they received? This is an important study that will help us evaluate the service and treatment offered by the Psychotic Disorders Clinic's specialized early intervention program,which helps young people experiencing early stages of psychotic illness.A growing body of evidence suggests that intervening earlier in the course of the illness with specialized and complimentary pharmacological and psychosocial treatment may be associated with improved outcomes.

Condition	Phase
Schizophreniform,First Episode Psychosis	Phase I

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study
Official Title:	Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic

Resource links provided by NLM:

MedlinePlus related topics: Psychotic Disorders

U.S. FDA Resources

Further study details as provided by McMaster University:

Study Start Date:

January 2004

Detailed Description:

The project is primarily a descriptive study of individuals experiencing their first episode of psychosis presenting at the Psychotic Disorders Clinic/Early Intervention Program.

The objectives of the study are:

Track multi-dimensional outcomes within the program
Track service use
Compare outcomes for this early intervention program with outcomes noted in published follow up studies
Evaluate effectiveness of the Psychotic Disorders Clinic in improving outcomes for persons experiencing their first episode of psychosis

Eligibility

Ages Eligible for Study:	16 Years to 50 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

male or female between ages of 16 to 50 years of age
capable of providing informed consent
receiving treatment voluntarily
experiencing a "first episode of psychosis" defined as the first episode of illness and where the subject,at presentation,meets DSM-IV criteria for one of the following diagnoses:schizophrenia,schizophreniform disorder,schizoaffective disorder,brief psychotic disorder,delusional disorder,and psychosis NOS

Exclusion Criteria:

primary diagnosis of mood disorder
diagnosis of substance-induced psychosis
diagnosis of psychosis due to a general medical condition
diagnosis of mental retardation
diagnosis of developmental disorder
has received antipsychotic treatment for greater than 1 month
has received treatment for an earlier episode of psychosis from which there has been a remission of symptoms for greater than 3 months

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00248027

Locations

Canada, Ontario
Cleghorn Program-Early Intervention in Psychosis.St Joseph's Healthcare Hamilton/Hamilton Health Sciences
Hamilton, Ontario, Canada, L8N 1Y2

Sponsors and Collaborators

Hamilton Health Sciences

Investigators

Principal Investigator:

Suzanne Archie, MD,FRCP(C)

Assistant Professor Dept of Psychiatry and Behavioural Neurosciences McMaster University.Active Medical Staff Hamilton Health Sciences.Clinical Director of Cleghorn Early Intervention in Psychosis Program and Psychotic Disorders Clinic

More Information

No publications provided

Study ID Numbers:	REB #04-203
Study First Received:	November 1, 2005
Last Updated:	September 12, 2006
ClinicalTrials.gov Identifier:	NCT00248027 History of Changes
Health Authority:	Canada: Ethics Review Committee

Keywords provided by McMaster University:

early intervention,program evaluation

Study placed in the following topic categories:

Schizophrenia
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

Additional relevant MeSH terms:

Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on September 02, 2009